Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Merck & Co., Inc. (MRK) had Cost of Goods Sold of $3.56B for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$15.81B |
|
$4.43B |
|
|
Cost of Goods Sold |
$3.56B |
$12.25B |
|
$10.25B |
|
$5.55B |
|
$-553.00M |
|
$5.00B |
|
$5.56B |
|
$4.43B |
|
$4.43B |
|
$4.43B |
|
$5.05B |
|
$5.55B |
|
$6.67B |
|
2.51B |
|
2.51B |
|
$1.76 |
|
$1.76 |
|
| Balance Sheet Financials | |
$37.06B |
|
$25.24B |
|
$80.46B |
|
$117.52B |
|
$26.04B |
|
$33.97B |
|
$42.43B |
|
$68.46B |
|
$49.06B |
|
$12.28B |
|
$49.06B |
|
2.50B |
|
| Cash Flow Statement Financials | |
$5.79B |
|
$-2.26B |
|
$-9.31B |
|
$13.32B |
|
$8.07B |
|
$-5.25B |
|
$411.00M |
|
$-4.13B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.42 |
|
-- |
|
-- |
|
0.41 |
|
0.72 |
|
77.50% |
|
35.13% |
|
35.13% |
|
-- |
|
31.63% |
|
28.01% |
|
$3.70B |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.54 |
|
1.33 |
|
67.45 |
|
9.03% |
|
36.07% |
|
3.77% |
|
5.33% |
|
$19.60 |
|
$1.47 |
|
$2.31 |
|